Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason J Paris

Showing results (51-60 of 78) with videos related to

Pageof 8
Sort By:
Neuroscience Letters|January 7, 2017
HIV-1 Tat disrupts blood-brain barrier integrity and increases phagocytic perivascular macrophages and microglia in the dorsal striatum of transgenic miceCrystal R Leibrand, Jason J Paris, M Said Ghandour, et al.
Communications Chemistry|March 28, 2026
Cannabidiphorol (CBDP) acts as a negative allosteric modulator at two distinct sites of cannabinoid receptor 1Pankaj Pandey, Ayat Hesham Zagzoog, Theodor Zaharia, et al.
Journal of Neuroendocrinology|October 15, 2021
Allopregnanolone and neuroHIV: Potential benefits of neuroendocrine modulation in the era of antiretroviral therapyMohammed F Salahuddin, Alaa N Qrareya, Fakhri Mahdi, et al.
Hormones and Behavior|June 23, 2009
Sex differences in salivary cortisol in response to acute stressors among healthy participants, in recreational or pathological gamblers, and in those with posttraumatic stress disorderJason J Paris, Christine Franco, Ruthlyn Sodano, et al.
Neurobiology of Disease|February 5, 2016
Central HIV-1 Tat exposure elevates anxiety and fear conditioned responses of male mice concurrent with altered mu-opioid receptor-mediated G-protein activation and β-arrestin 2 activity in the forebrainYun K Hahn, Jason J Paris, Aron H Lichtman, et al.
Neuroscience Letters|September 7, 2019
Cell-type specific differences in antiretroviral penetration and the effects of HIV-1 Tat and morphine among primary human brain endothelial cells, astrocytes, pericytes, and microgliaSulay H Patel, Omnia A Ismaiel, William R Mylott, et al.
European Journal of Pain (London, England)|June 14, 2020
Conditional expression of HIV-1 tat in the mouse alters the onset and progression of tonic, inflammatory and neuropathic hypersensitivity in a sex-dependent mannerDeniz Bagdas, Jason J Paris, Moriah Carper, et al.
Journal of Neurovirology|May 15, 2016
HIV-1 Tat causes cognitive deficits and selective loss of parvalbumin, somatostatin, and neuronal nitric oxide synthase expressing hippocampal CA1 interneuron subpopulationsWilliam D Marks, Jason J Paris, Christina J Schier, et al.
Molecules (Basel, Switzerland)|January 21, 2022
Identification of an Orally Bioavailable, Brain-Penetrant Compound with Selectivity for the Cannabinoid Type 2 ReceptorMeirambek Ospanov, Suresh P Sulochana, Jason J Paris, et al.
Brain, Behavior, and Immunity|November 18, 2017
CCR5 mediates HIV-1 Tat-induced neuroinflammation and influences morphine tolerance, dependence, and rewardMaciej Gonek, Virginia D McLane, David L Stevens, et al.
Pageof 8

Showing results (51-60 of 78) with videos related to

Sort By:
Pageof 8
Neuroscience Letters|January 7, 2017
HIV-1 Tat disrupts blood-brain barrier integrity and increases phagocytic perivascular macrophages and microglia in the dorsal striatum of transgenic miceCrystal R Leibrand, Jason J Paris, M Said Ghandour, et al.
Communications Chemistry|March 28, 2026
Cannabidiphorol (CBDP) acts as a negative allosteric modulator at two distinct sites of cannabinoid receptor 1Pankaj Pandey, Ayat Hesham Zagzoog, Theodor Zaharia, et al.
Journal of Neuroendocrinology|October 15, 2021
Allopregnanolone and neuroHIV: Potential benefits of neuroendocrine modulation in the era of antiretroviral therapyMohammed F Salahuddin, Alaa N Qrareya, Fakhri Mahdi, et al.
Hormones and Behavior|June 23, 2009
Sex differences in salivary cortisol in response to acute stressors among healthy participants, in recreational or pathological gamblers, and in those with posttraumatic stress disorderJason J Paris, Christine Franco, Ruthlyn Sodano, et al.
Neurobiology of Disease|February 5, 2016
Central HIV-1 Tat exposure elevates anxiety and fear conditioned responses of male mice concurrent with altered mu-opioid receptor-mediated G-protein activation and β-arrestin 2 activity in the forebrainYun K Hahn, Jason J Paris, Aron H Lichtman, et al.
Neuroscience Letters|September 7, 2019
Cell-type specific differences in antiretroviral penetration and the effects of HIV-1 Tat and morphine among primary human brain endothelial cells, astrocytes, pericytes, and microgliaSulay H Patel, Omnia A Ismaiel, William R Mylott, et al.
European Journal of Pain (London, England)|June 14, 2020
Conditional expression of HIV-1 tat in the mouse alters the onset and progression of tonic, inflammatory and neuropathic hypersensitivity in a sex-dependent mannerDeniz Bagdas, Jason J Paris, Moriah Carper, et al.
Journal of Neurovirology|May 15, 2016
HIV-1 Tat causes cognitive deficits and selective loss of parvalbumin, somatostatin, and neuronal nitric oxide synthase expressing hippocampal CA1 interneuron subpopulationsWilliam D Marks, Jason J Paris, Christina J Schier, et al.
Molecules (Basel, Switzerland)|January 21, 2022
Identification of an Orally Bioavailable, Brain-Penetrant Compound with Selectivity for the Cannabinoid Type 2 ReceptorMeirambek Ospanov, Suresh P Sulochana, Jason J Paris, et al.
Brain, Behavior, and Immunity|November 18, 2017
CCR5 mediates HIV-1 Tat-induced neuroinflammation and influences morphine tolerance, dependence, and rewardMaciej Gonek, Virginia D McLane, David L Stevens, et al.
Pageof 8